By delivering glutathione directly into the bloodstream, this IV therapy supports antioxidant protection, skin clarity, and overall wellnesshelping your skin appear smoother, more luminous, and revitalized over time
Based on the clinical evidence and the patient profiles where the compound appears most applicable, the following characteristics tend to describe good candidates for AOD 9604 evaluation when it is medically supervised: Patients with stubborn localized fat deposits that have not responded to diet and exercise, particularly visceral and lower abdominal fat Patients who cannot tolerate GLP-1 medications due to nausea, gastrointestinal side effects, or contraindications Active patients with reasonable baseline metabolic health who want a targeted lipolytic tool to complement their training and nutrition program Patients already on a peptide protocol who want to add a fat-targeting element to a GHK-Cu, NAD+, or sermorelin stack Patients who are not candidates for stimulant-based fat loss medications due to cardiovascular sensitivity, anxiety, or blood pressure concerns AOD 9604 is not appropriate as a standalone weight loss strategy for patients with significant obesity, insulin resistance, or metabolic syndrome
They primarily work by mimicking a gut hormone that slows digestion, reduces appetite, and improves insulin secretion
While SLU-PP-332 shows promising results in oncology and neurodegenerative disorders, 5-amino-1mq has a more established track record in metabolic health and aging-related conditions
active ulcer, serious liver disease, hypotension, or gout)
